TNF and inflammatory bowel disease: In the Swiss IBD cohort of 3119 patients, increased lymphoma rates with anti-TNF were found in both CD (HR 3.26, 95% CI: 1.31–8.10) and UC patients (HR 25.25, 95% CI: 2.94–217.26) [74].